Back to top

Image: Bigstock

Can CME Group Sustain Trading Momentum Amid Easing Volatility?

Read MoreHide Full Article

Key Takeaways

  • CME's Q2 average daily volume reached 29.8M contracts, the second-highest second-quarter level on record.
  • Equity index ADV rose 13% and agricultural ADV gained 6%, offsetting declines in other trading segments.
  • Product diversification and electronic trading could support volumes as market volatility normalizes.

CME Group Inc. (CME - Free Report) appears capable of sustaining healthy trading volumes over the longer term, although growth may moderate as market volatility normalizes. CME's diversified derivatives portfolio, expanding product offerings and global demand for risk-management tools provide support beyond short-term market uncertainty. However, trading activity remains sensitive to interest-rate expectations, commodity-price movements and geopolitical developments, making it difficult to sustain peak volumes consistently.

In the second quarter of 2026, CME's average daily volume (ADV) reached 29.8 million contracts, down 1.2% year over year but still the second-highest second-quarter level on record. Performance varied across asset classes, highlighting the importance of diversification in supporting overall activity. The results suggest that CME can maintain substantial trading volumes even when growth moderates, although the pace of expansion will depend on participation across its major markets.

CME's diversified product mix is a key advantage. Equity index ADV rose 13% year over year, agricultural ADV increased 6%, and metals activity was broadly flat. These gains helped offset declines in interest-rate, energy and foreign-exchange trading. In addition, electronic trading and growing international participation offer opportunities to attract customers across different market conditions. 

However, the sustainability of trading-volume growth will depend on CME's ability to generate demand beyond periods of heightened uncertainty. Softer volatility can reduce hedging and speculative activity, while competition from alternative derivatives products could affect market share. 

Overall, CME can sustain substantial trading volumes, but consistently growing them will be challenging if market volatility declines. Product diversification, international expansion and new derivatives offerings should help cushion cyclical fluctuations, while record trading levels may be difficult to replicate without renewed market catalysts.

What About Its Peers?

Intercontinental Exchange, Inc. (ICE - Free Report) appears positioned to sustain exchange growth even as market volatility normalizes, although the pace may moderate from elevated levels. The company's diversified product portfolio across financial futures, energy, cash equities and equity options, along with recurring data and connectivity revenues, provides multiple growth drivers. Moreover, recurring exchange revenues grew 10%, providing a more stable source of income. Overall, ICE's diversified revenue streams and recurring data business should help cushion the impact of normalizing volatility, although softer energy trading and fluctuations in transaction volumes remain key risks.

Cboe Global Markets, Inc. (CBOE - Free Report) may be able to sustain trading-volume growth as market volatility normalizes, although performance will depend on whether demand for options and volatility-linked products remains strong. Cboe Global's diversified business across options, U.S. and European equities, futures and global foreign exchange provides multiple sources of trading activity. Its options franchise, particularly SPX index options and VIX futures and options, benefits from investors' demand for portfolio hedging, income generation and risk management. This product mix can help Cboe Global attract trading activity even when market conditions become less volatile.

CME’s Price Performance

Shares of CME have gained 3.4% in the past year, outperforming the industry.

Zacks Investment Research
Image Source: Zacks Investment Research

CME’s Overvaluation

The stock is overvalued compared with its industry. It is currently trading at a price-to-earnings multiple of 22.02, higher than the industry average of 20.33.

Zacks Investment Research
Image Source: Zacks Investment Research

Estimate Movement for CME

The Zacks Consensus Estimate for CME’s fourth-quarter 2026 EPS has moved up 0.3% in the past 30 days. The same for full-year 2026 and 2027 EPS has moved up 0.2% and 0.4%, respectively, in the past 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

The consensus estimate for CME’s 2026 and 2027 EPS and revenues indicates a year-over-year increase. 

CME stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Published in